OCS™ Liver
Currently being evaluated in clinical trials for utilized and unutilized donor livers
Actively Enrolling in US FDA Pivotal Trial for Extended Criteria and DCD Donor Livers
A prospective, pivotal, randomized trial to evaluate the effectiveness of the OCS Liver to preserve and assess donor livers intended for transplantation.
- Incidence of Early Liver Allograft Dysfunction (EAD) [ Time Frame: 7 days ]
- Incidence of liver graft related Serious Adverse Events (SAEs) [ Time Frame: 30 days ]
The OCS is designed to enable surgeons to transplant more organs from the available donor pool and to achieve better procedural outcomes.
ClinicalTrials.gov Identifier: NCT02522871
Locate an OCS Liver Trial Center
The OCS Liver System is undergoing clinical trials in the US. The OCS Liver device is an investigational device limited by federal law to investigational use in the US.
Massachusetts General Hospital
Main Campus
55 Fruit Street
Boston, MA 02114
(617) 726-2000
Houston Methodist Hospital
6565 Fannin St
Houston, TX 77030
Henry Ford Hospital
2799 W Grand Blvd
Detroit, MI 48202
UT Southwestern Medical Center
5323 Harry Hines Blvd
Dallas, TX 75390
University of Virginia HSC
1189-1221 Lee St
Charlottesville, VA 22903
(800) 251-3627
MCV Hospitals
1250 East Marshall Street
Richmond, VA 23298
(804) 828-4104
Emory University Hospital
Johns Hopkins Hospital
1800 Orleans St
Baltimore, MD 21287
(410) 955-5000
University of Minnesota Medical Center
909 Fulton St. SE
Minneapolis, MN 55455
(612) 273-8383
University of Washington Medical Center
9725 3rd Ave NE #400
Seattle, WA 98115
(206) 598-3300
University of CA San Francisco Medical Center
505 Parnassus Ave
San Francisco, CA 94143
(415) 353-1664
Ohio State University Medical Center
410 W 10th Ave
Columbus, OH 43210
The OCS Lung, OCS Heart and OCS Liver are all CE marked devices.
The OCS Lung is an FDA-approved device for utilized donor lungs. The OCS Heart and OCS Liver devices are investigational devices and, therefore, are limited by federal law to investigational use in the US.
ONLY
multi-organ platform
SUBSTANTIAL
body of clinical evidence